Related Experiment Video
Updated: May 31, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
[Endocrinology : what's new in 2024].
Adelina Ameti1, Karim Cruchon1, Ilaria Giordani1
1Unité d'endocrinologie, Service d'endocrinologie, diabétologie et métabolisme,Département de médecine, Centre hospitalier universitaire vaudois, 1011 Lausanne.
This review covers recent endocrinology advances, including Glucagon-Like Peptide-1 (GLP1) analogue thyroid safety, adrenal surgery for cortisol issues, and new treatments for congenital adrenal hyperplasia, acromegaly, and hypoparathyroidism.
Area of Science:
- Endocrinology
- Pharmacotherapy
- Endocrine Surgery
Context:
- Rapid advancements in endocrine treatments necessitate a review of current therapeutic landscapes.
- Emerging pharmacotherapies and surgical interventions offer new hope for endocrine disorders.
Purpose:
- To provide an overview of significant recent developments in key areas of endocrinology.
- To highlight novel therapeutic strategies and their clinical implications.
Summary:
- Examines the thyroid safety of Glucagon-Like Peptide-1 (GLP1) analogues.
- Assesses the efficacy of adrenal surgery for mild autonomous cortisol secretion.
- Reviews crinecerfont for congenital adrenal hyperplasia (CAH) in all age groups.
- Discusses paltusotin, a new oral treatment for acromegaly.
- Highlights TransCon PTH (palopegteriparatide) for chronic hypoparathyroidism.
Impact:
- Informs clinicians about the latest evidence in endocrine pharmacotherapy and surgery.
- Supports evidence-based decision-making for managing complex endocrine conditions.
- Facilitates the integration of novel therapies into clinical practice.
Related Concept Videos
What is the Endocrine System?
An Overview of the Endocrine System
The endocrine system collaborates...
The Endocrine System
Structures of the Endocrine System
Hormonal Regulation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

